Abiraterone Acetate (Zytiga® tablets - Janssen Biotech, generic) — Cigna
Prostate Cancer – Metastatic, Castration-Resistant
Initial criteria
- Patient age ≥ 18 years
- Medication is used in combination with prednisone or dexamethasone
- Patient meets ONE of the following: (i) Medication is concurrently used with a gonadotropin-releasing hormone (GnRH) analog OR (ii) Patient has had a bilateral orchiectomy
Approval duration
1 year